Suwon, South Korea

Dong-Hyun Lee

This inventor holds 1 USPTO granted patent. Top assignee: Ajou University Industry-Academic Cooperation Foundation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dong-Hyun Lee. Retrieved from https://idiyas.com/inventor/dong-hyun-lee-o7kd9ecs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dong-Hyun Lee: Inventor in Biopharmaceutical Research

Introduction

Dong-Hyun Lee is an inventor associated with Suwon, South Korea. His patent work concerns a bispecific antibody designed to bind two receptor subunits involved in immune signaling.

Latest Patents

Lee is listed on one patent: “Bispecific Antibody Simultaneously Binding to Interleukin-4 Receptor Alpha Subunit and Interleukin-5 Receptor Alpha Subunit, Encoding Nucleic Acids Thereof and Methods of Use Thereof for Treatment.” The invention describes an antibody that targets both receptor subunits, along with related nucleic acids and proposed therapeutic uses. 1 patent

Career Highlights

Lee is associated with Ajou University Industry-Academic Cooperation Foundation, which supports collaboration between university research and industry. His listed patent reflects work in antibody-based therapeutic research.

Collaborations

Lee’s listed coworker is Hae-Sim Park. Their shared patent record connects their work to research on targeting interleukin receptors.

Conclusion

Dong-Hyun Lee’s recorded invention focuses on a bispecific antibody approach to therapeutic research, developed in association with Ajou University Industry-Academic Cooperation Foundation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…